Effects of bevacizumab combination therapy on transcriptional changes in responding and non-responding recurrent glioblastoma patients

Thomas Urup; Signe Regner Michaelsen; Line Mærsk Staunstrup; Kristoffer Vitting-Seerup; Marc Bennedbæk; Anders Toft; Lars Jønson; Helle Broholm; Petra Hamerlik; Hans Skovgaard Poulsen; Ulrik Lassen

Effects of bevacizumab combination therapy on transcriptional changes in responding and non-responding recurrent glioblastoma patients

Thomas Urup, Signe Regner Michaelsen, Line Mærsk Staunstrup, Kristoffer Vitting-Seerup, Marc Bennedbæk, Anders Toft, Lars Jønson, Helle Broholm, Petra Hamerlik, Hans Skovgaard Poulsen, Ulrik Lassen

Abstract

Original language	English
Publication date	2016
Publication status	Published - 2016
Event	The Scandinavian Society of Neuro-Oncology: Meeting 2016 - Odd Fellow Palace, Copenhagen, Denmark Duration: 19 May 2016 → 21 May 2016

Conference

Conference	The Scandinavian Society of Neuro-Oncology
Location	Odd Fellow Palace
Country/Territory	Denmark
City	Copenhagen
Period	19/05/2016 → 21/05/2016

Cite this

Urup, T., Michaelsen, S. R., Staunstrup, L. M., Vitting-Seerup, K., Bennedbæk, M., Toft, A., Jønson, L., Broholm, H., Hamerlik, P., Poulsen, H. S., & Lassen, U. (2016). Effects of bevacizumab combination therapy on transcriptional changes in responding and non-responding recurrent glioblastoma patients. Abstract from The Scandinavian Society of Neuro-Oncology, Copenhagen, Denmark.

Effects of bevacizumab combination therapy on transcriptional changes in responding and non-responding recurrent glioblastoma patients. / Urup, Thomas; Michaelsen, Signe Regner; Staunstrup, Line Mærsk et al.
2016. Abstract from The Scandinavian Society of Neuro-Oncology, Copenhagen, Denmark.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Urup, T, Michaelsen, SR, Staunstrup, LM, Vitting-Seerup, K, Bennedbæk, M, Toft, A, Jønson, L, Broholm, H, Hamerlik, P, Poulsen, HS & Lassen, U 2016, 'Effects of bevacizumab combination therapy on transcriptional changes in responding and non-responding recurrent glioblastoma patients', The Scandinavian Society of Neuro-Oncology, Copenhagen, Denmark, 19/05/2016 - 21/05/2016.

@conference{d70a78cd41fb4289ab1627e8c913009c,

title = "Effects of bevacizumab combination therapy on transcriptional changes in responding and non-responding recurrent glioblastoma patients",

author = "Thomas Urup and Michaelsen, {Signe Regner} and Staunstrup, {Line M{\ae}rsk} and Kristoffer Vitting-Seerup and Marc Bennedb{\ae}k and Anders Toft and Lars J{\o}nson and Helle Broholm and Petra Hamerlik and Poulsen, {Hans Skovgaard} and Ulrik Lassen",

year = "2016",

language = "English",

note = "The Scandinavian Society of Neuro-Oncology : Meeting 2016 ; Conference date: 19-05-2016 Through 21-05-2016",

}

TY - ABST

T1 - Effects of bevacizumab combination therapy on transcriptional changes in responding and non-responding recurrent glioblastoma patients

AU - Urup, Thomas

AU - Michaelsen, Signe Regner

AU - Staunstrup, Line Mærsk

AU - Vitting-Seerup, Kristoffer

AU - Bennedbæk, Marc

AU - Toft, Anders

AU - Jønson, Lars

AU - Broholm, Helle

AU - Hamerlik, Petra

AU - Poulsen, Hans Skovgaard

AU - Lassen, Ulrik

PY - 2016

Y1 - 2016

M3 - Conference abstract for conference

T2 - The Scandinavian Society of Neuro-Oncology

Y2 - 19 May 2016 through 21 May 2016

ER -